335 related articles for article (PubMed ID: 10515453)
1. Engraftment of hematopoietic progenitor cells transduced with the Fanconi anemia group C gene (FANCC).
Liu JM; Kim S; Read EJ; Futaki M; Dokal I; Carter CS; Leitman SF; Pensiero M; Young NS; Walsh CE
Hum Gene Ther; 1999 Sep; 10(14):2337-46. PubMed ID: 10515453
[TBL] [Abstract][Full Text] [Related]
2. Retroviral mediated gene transfer of the Fanconi anemia complementation group C gene to hematopoietic progenitors of group C patients.
Liu JM; Young NS; Walsh CE; Cottler-Fox M; Carter C; Dunbar C; Barrett AJ; Emmons R
Hum Gene Ther; 1997 Sep; 8(14):1715-30. PubMed ID: 9322874
[TBL] [Abstract][Full Text] [Related]
3. A functionally active retrovirus vector for gene therapy in Fanconi anemia group C.
Walsh CE; Grompe M; Vanin E; Buchwald M; Young NS; Nienhuis AW; Liu JM
Blood; 1994 Jul; 84(2):453-9. PubMed ID: 7517716
[TBL] [Abstract][Full Text] [Related]
4. Persistent low-level engraftment of rhesus peripheral blood progenitor cells transduced with the fanconi anemia C gene after conditioning with low-dose irradiation.
Kang EM; Hanazano Y; Frare P; Vanin EF; De Witte M; Metzger M; Liu JM; Tisdale JF
Mol Ther; 2001 Jun; 3(6):911-9. PubMed ID: 11407905
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector.
Walsh CE; Nienhuis AW; Samulski RJ; Brown MG; Miller JL; Young NS; Liu JM
J Clin Invest; 1994 Oct; 94(4):1440-8. PubMed ID: 7929819
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic correction of Fanconi anemia group C knockout mice.
Gush KA; Fu KL; Grompe M; Walsh CE
Blood; 2000 Jan; 95(2):700-4. PubMed ID: 10627482
[TBL] [Abstract][Full Text] [Related]
7. Transduction of CD34-enriched human peripheral and umbilical cord blood progenitors using a retroviral vector with the Fanconi anemia group C gene.
Walsh CE; Mann MM; Emmons RV; Wang S; Liu JM
J Investig Med; 1995 Aug; 43(4):379-85. PubMed ID: 7552587
[TBL] [Abstract][Full Text] [Related]
8. Hematopoietic stem cells from fancc(-/-) mice have lower growth and differentiation potential in response to growth factors.
Aubé M; Lafrance M; Charbonneau C; Goulet I; Carreau M
Stem Cells; 2002; 20(5):438-47. PubMed ID: 12351814
[TBL] [Abstract][Full Text] [Related]
9. In vitro phenotypic correction of hematopoietic progenitors from Fanconi anemia group A knockout mice.
Río P; Segovia JC; Hanenberg H; Casado JA; Martínez J; Göttsche K; Cheng NC; Van de Vrugt HJ; Arwert F; Joenje H; Bueren JA
Blood; 2002 Sep; 100(6):2032-9. PubMed ID: 12200363
[TBL] [Abstract][Full Text] [Related]
10. Retroviral-mediated expression of recombinant Fancc enhances the repopulating ability of Fancc-/- hematopoietic stem cells and decreases the risk of clonal evolution.
Haneline LS; Li X; Ciccone SL; Hong P; Yang Y; Broxmeyer HE; Lee SH; Orazi A; Srour EF; Clapp DW
Blood; 2003 Feb; 101(4):1299-307. PubMed ID: 12393504
[TBL] [Abstract][Full Text] [Related]
11. Functional correction of fanconi anemia group C hematopoietic cells by the use of a novel lentiviral vector.
Yamada K; Olsen JC; Patel M; Rao KW; Walsh CE
Mol Ther; 2001 Apr; 3(4):485-90. PubMed ID: 11319908
[TBL] [Abstract][Full Text] [Related]
12. In vivo administration of interferon gamma does not cause marrow aplasia in mice with a targeted disruption of FANCC.
Kurre P; Anandakumar P; Grompe M; Kiem HP
Exp Hematol; 2002 Nov; 30(11):1257-62. PubMed ID: 12423678
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy of Fanconi anemia: preclinical efficacy using lentiviral vectors.
Galimi F; Noll M; Kanazawa Y; Lax T; Chen C; Grompe M; Verma IM
Blood; 2002 Oct; 100(8):2732-6. PubMed ID: 12351379
[TBL] [Abstract][Full Text] [Related]
14. Retroviral transfer of the glucocerebrosidase gene into CD34+ cells from patients with Gaucher disease: in vivo detection of transduced cells without myeloablation.
Dunbar CE; Kohn DB; Schiffmann R; Barton NW; Nolta JA; Esplin JA; Pensiero M; Long Z; Lockey C; Emmons RV; Csik S; Leitman S; Krebs CB; Carter C; Brady RO; Karlsson S
Hum Gene Ther; 1998 Nov; 9(17):2629-40. PubMed ID: 9853529
[TBL] [Abstract][Full Text] [Related]
15. [Progress of research on protein composition and gene therapy of Fanconi anaemia - review].
Li ZY; Zou YF; Deng YB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Apr; 12(2):231-5. PubMed ID: 15157341
[TBL] [Abstract][Full Text] [Related]
16. Functional correction of Fanconi anemia group A hematopoietic cells by retroviral gene transfer.
Fu KL; Foe JR; Joenje H; Rao KW; Liu JM; Walsh CE
Blood; 1997 Nov; 90(9):3296-303. PubMed ID: 9345011
[TBL] [Abstract][Full Text] [Related]
17. Continuous in vivo infusion of interferon-gamma (IFN-gamma) preferentially reduces myeloid progenitor numbers and enhances engraftment of syngeneic wild-type cells in Fancc-/- mice.
Li X; Yang Y; Yuan J; Hong P; Freie B; Orazi A; Haneline LS; Clapp DW
Blood; 2004 Aug; 104(4):1204-9. PubMed ID: 15113761
[TBL] [Abstract][Full Text] [Related]
18. The Fanconi anemia protein FANCC binds to and facilitates the activation of STAT1 by gamma interferon and hematopoietic growth factors.
Pang Q; Fagerlie S; Christianson TA; Keeble W; Faulkner G; Diaz J; Rathbun RK; Bagby GC
Mol Cell Biol; 2000 Jul; 20(13):4724-35. PubMed ID: 10848598
[TBL] [Abstract][Full Text] [Related]
19. Fanconi anemia group A and C double-mutant mice: functional evidence for a multi-protein Fanconi anemia complex.
Noll M; Battaile KP; Bateman R; Lax TP; Rathbun K; Reifsteck C; Bagby G; Finegold M; Olson S; Grompe M
Exp Hematol; 2002 Jul; 30(7):679-88. PubMed ID: 12135664
[TBL] [Abstract][Full Text] [Related]
20. Preclinical protocol for in vivo selection of hematopoietic stem cells corrected by gene therapy in Fanconi anemia group C.
Noll M; Bateman RL; D'Andrea AD; Grompe M
Mol Ther; 2001 Jan; 3(1):14-23. PubMed ID: 11162306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]